Vertebral Balloon System Enables Targeted Placement
|
By HospiMedica International staff writers Posted on 18 Feb 2014 |

Image: The AVAflex Vertebral Balloon System in place in vertebral level L10 (Photo courtesy of CareFusion).
A minimally invasive vertebral augmentation system treats vertebral compression fractures (VCFs), while also promoting patient safety.
The AVAflex Vertebral Balloon System combines a curved vertebral augmentation needle and a vertebral balloon to enable targeted balloon placement across the midline of the vertebral body, followed by targeted cement placement for optimal fill, all through a single pedicle. The curved needle is made from nitinol, a superelastic composite made of nickel and titanium. The ultraflexible qualities of nitinol allow the curved augmentation needle to target hard to reach areas in the vertebral body, allowing maneuverability and flexibility in creating a cavity in the vertebral body prior to balloon insertion.
The AVAmax vertebral balloon, in turn, allows the surgeon to perform kyphoplasty in areas where a larger balloon might prohibit the procedure. Each catheter contains a durable balloon filled with a contrast agent to aid visualization when creating a void in the vertebral body, as well as clearly defined marker bands on the shaft to help identify correct advancement and placement. A digital pressure monitor at the tip of the inflation syringe helps to monitor pressure levels. At the touch of a button, balloon pressure can be shown in either atmospheres or PSI.
An important feature of the system is that it allows bilateral fracture reduction using a unilateral pediclular approach. Access kits and inflation syringes are packaged single and sterile, minimizing waste and improving operational efficiency. The AVAflex Vertebral Balloon System is a product of CareFusion (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
“The unipedicular approach offers a less risky approach to the midline of a vertebral body,” said Allan Brook, MD, an interventional radiologist with Montefiore Medical Center (New York, NY, USA). “Having another tool that places the cavity in the desired location can improve the effectiveness of vertebral augmentation in less time and with less radiation.”
Kyphoplasty uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore the vertebrae to a more normal shape. Subsequently, a cement-like material is injected into the space created by the balloon to retain the correction. By restoring the vertebrae to a more normal state, alignment of the spine may be improved.
Related Links:
CareFusion
The AVAflex Vertebral Balloon System combines a curved vertebral augmentation needle and a vertebral balloon to enable targeted balloon placement across the midline of the vertebral body, followed by targeted cement placement for optimal fill, all through a single pedicle. The curved needle is made from nitinol, a superelastic composite made of nickel and titanium. The ultraflexible qualities of nitinol allow the curved augmentation needle to target hard to reach areas in the vertebral body, allowing maneuverability and flexibility in creating a cavity in the vertebral body prior to balloon insertion.
The AVAmax vertebral balloon, in turn, allows the surgeon to perform kyphoplasty in areas where a larger balloon might prohibit the procedure. Each catheter contains a durable balloon filled with a contrast agent to aid visualization when creating a void in the vertebral body, as well as clearly defined marker bands on the shaft to help identify correct advancement and placement. A digital pressure monitor at the tip of the inflation syringe helps to monitor pressure levels. At the touch of a button, balloon pressure can be shown in either atmospheres or PSI.
An important feature of the system is that it allows bilateral fracture reduction using a unilateral pediclular approach. Access kits and inflation syringes are packaged single and sterile, minimizing waste and improving operational efficiency. The AVAflex Vertebral Balloon System is a product of CareFusion (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
“The unipedicular approach offers a less risky approach to the midline of a vertebral body,” said Allan Brook, MD, an interventional radiologist with Montefiore Medical Center (New York, NY, USA). “Having another tool that places the cavity in the desired location can improve the effectiveness of vertebral augmentation in less time and with less radiation.”
Kyphoplasty uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore the vertebrae to a more normal shape. Subsequently, a cement-like material is injected into the space created by the balloon to retain the correction. By restoring the vertebrae to a more normal state, alignment of the spine may be improved.
Related Links:
CareFusion
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







